NDC 0143-9721-01 - Levofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9721
- Requested NDC
- 0143-9721-01
- Package NDCs from labels
- 0143-9721-01, 0143-9721-24
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2019-03-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levofloxacin - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2019-03-28 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9721-01 | Levofloxacin | 100 mL in 1 BAG | INJECTION, SOLUTION | 100 | 12 | |
| 0143-9721-24 | Levofloxacin | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9721-01 | ML - Milliliter | 0143-9721 | 4f7ffbd1-d911-4ec3-b828-3cd7ff9fc0f7 | 1 | 2013-02-13 |
| 0143-9721-24 | ML - Milliliter | 0143-9721 | 1d2bf451-0858-4573-afa9-f7bf8356056c | 1 | 2013-12-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOFLOXACIN | ACTIVE INGREDIENT | 6GNT3Y5LMF | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| LEVOFLOXACIN ANHYDROUS | ACTIVE MOIETY | RIX4E89Y14 | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals Inc | 067e260c-dc47-4957-a9ff-5a79f17b4ca0 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | LX22YL083G | |
| Levofloxacin | LEVOFLOXACIN | DirectRx | dabedb15-5b55-3853-e053-2995a90aa44e | 2025-01-21 | Warnings, Adverse reactions | 6GNT3Y5LMF |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | LX22YL083G |
| D-114 | ALUMINUM METALLICUM, AILANTHUS, BAPTISIA TINCTORIA, FRAGARIA VESCA, YOSCYAMUS NIGER, MURIATICUM ACID | DNA Labs | f6f7d369-64ef-0ed9-e053-6294a90a40fa | 2025-01-13 | Warnings | QTT17582CB |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | NuCare Pharmaceuticals,Inc. | 8423b021-e09c-4f1c-e053-2991aa0afef6 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS IUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOSPHORUS, STAPHYSAGRIA, STRAMONIUM | Silver Star Brands | 05e04129-e7c1-4e11-e063-6394a90a09ca | 2025-01-01 | Warnings | QTT17582CB |
| Levofloxacin | LEVOFLOXACIN | ADVANCED RX PHARMACY OF TENNESSEE, LLC | af4b7333-4f77-4ec9-e053-2a95a90a16d2 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Advanced Rx of Tennessee, LLC | afd5cb35-4232-f8b1-e053-2a95a90a8c5b | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Advanced Rx of Tennessee, LLC | b001d60e-b8fb-54ff-e053-2a95a90a2970 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Stress Away Anxiety Relief | ACONITUM NAP, ALFALFA, AVENA, CHAMOMILLA, GELSEMIUM, HUMULUS LUPULUS, IGNATIA, KALI ARS, KALI PHOS, MURIATICUM AC, NAT PHOS, PASSIFLORA, PHOS, STAPHYSAG, STRAMONIUM | Silver Star Brands | 9d75666e-3214-2bab-e053-2a95a90af719 | 2024-12-03 | Warnings | QTT17582CB |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | d3f90d2f-4536-4d32-800b-7a798f8a35db | 2024-11-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 68cc9c41-ed24-4f76-8efb-2936ae3ddd8d | 2024-10-29 | Warnings, Adverse reactions | LX22YL083G |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | LX22YL083G |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | WG Critical Care, LLC | 9020cdeb-65fe-458f-bbbd-69265a49906e | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | 1665497 1665515 1665507 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | A-S Medication Solutions | bdc8b2cc-a914-4613-ac7c-e8dfe91dea13 | 2024-09-29 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | Golden State Medical Supply, Inc. | bfe280be-0789-69fa-e053-2a95a90a0e13 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.